ALC - Spark Newswire

1 minute read

Earnings

Alcon: Q2 Earnings Insights

Today, 5:05 PM

Alcon (NYSE:ALC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Alcon beat estimated earnings by 28.57%, reporting an EPS of $0.63 versus an estimate of $0.49.

ALC

1 minute read

Alcon Q2 EPS $0.63 Beats $0.49 Estimate, Sales $2.20B Beat $2.04B Estimate

By Michael Horton

Today, 5:05 PM

Alcon (NYSE:ALC) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.49 by 28.57 percent. This is a 12.5 percent increase over earnings of $0.56 per share from the same period

ALC

22 minute read

Earnings Scheduled For August 9, 2022

By Benzinga Insights

Today, 5:05 PM

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

AAIC

1 minute read

Earnings

Earnings Preview For Alcon

By Benzinga Insights

Today, 5:05 PM

Alcon (NYSE:ALC) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Alcon will report an earnings per share (EPS) of $0.49.

ALC

4 minute read

LabCorp (LH) To Report Q2 Earnings: What’s In The Cards?

By Zacks

Today, 5:05 PM

Laboratory Corporation of America Holdings (NYSE: LH), also known as LabCorp, is slated to report second-quarter 2022 results on Jul 28, before market open.

ALC

1 minute read

This Biopharma Stock Surges After Offloading Its Ophthalmic Eye Drop Portfolio

By Vandana Singh

Today, 5:05 PM

Alcon AG (NYSE:ALC) has agreed to acquire Eysuvis (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals Inc (NASDAQ:KALA). Eysuvis will complement…

ALC

1 minute read

Morgan Stanley Maintains Equal-Weight on Alcon, Lowers Price Target to $83

By Benzinga Newsdesk

Today, 5:05 PM

Morgan Stanley maintains Alcon (NYSE:ALC) with a Equal-Weight and lowers the price target from $92 to $83.

ALC

1 minute read

Needham Maintains Buy on Alcon, Lowers Price Target to $87

By Benzinga Newsdesk

Today, 5:05 PM

Needham analyst David Saxon maintains Alcon (NYSE:ALC) with a Buy and lowers the price target from $95 to $87.

ALC

20 minute read

Earnings Scheduled For May 10, 2022

By Benzinga Insights

Today, 5:05 PM

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

ABCL